Phf2 silencing also increases liver oxidative damages compared to USi mice facilitating the conversion of NAFLD into fibrosis upon HFHSD feeding (Fig. 7g, h). This evidence concerns the gene PHF2 and metabolic dysfunction-associated steatotic liver disease.